Clinical trials · Oklahoma
Coagulation Disorder clinical trials in Oklahoma
We’re tracking 3 recruiting coagulation disorder studies with a site in Oklahoma — including Phase 3 studies, each written for real people, not researchers.
Recruiting studies in Oklahoma
- NCT04278404Recruiting
Drug safety study for children already on certain medicines
This study measures how certain medicines move through the body and checks their safety in children. It may help doctors better understand dosing and side effects in kids who are already receiving these treatments, or in some kids who recently tested positive for COVID-19.
Oklahoma City, OklahomaAges birth–20 years - NCT07288489RecruitingPhase 3
A study on VMX-C001 for urgent surgery while on blood thinners
This trial tests a drug called VMX-C001 to quickly reverse the effects of certain blood thinners (Factor Xa inhibitors) in people who need urgent surgery with a high risk of bleeding. It compares VMX-C001 to standard care to see which is more effective at helping blood clot normally.
Oklahoma City, OklahomaAges 18 years+ - NCT05156983RecruitingPhase 3
Reversal drug for urgent surgery in people on Factor Xa blood thinners
This Phase 3 study tests TAK-330, a reversal (blocking) medicine, to reduce bleeding risk during urgent surgery for adults taking Factor Xa inhibitors like rivaroxaban, apixaban, or edoxaban. It’s for situations where surgery can’t wait and doctors need a fast way to restore normal clotting.
Tulsa, OklahomaAges 18 years+
Where these studies are running in Oklahoma
Institutions with a site for the recruiting coagulation disorder studies listed above.
- University of Oklahoma Health Sciences Center · 2 studies
- Ascension St. John Medical Center
What taking part in a coagulation disorder study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Coagulation Disorder trials in other states
Common questions
- Are there coagulation disorder clinical trials in Oklahoma?
- Yes. We're currently tracking 3 recruiting coagulation disorder studies with a site in Oklahoma, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a coagulation disorder study in Oklahoma?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Oklahoma to take part?
- Not necessarily. These studies have a site in Oklahoma, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a coagulation disorder trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New coagulation disorder studies open in Oklahoma regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.